Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Objective The diagnosis and treatment of gynecologic cancer can cause short- and long-term negative effects on sexual health and quality of life (QoL). The aim of this article is to present a comprehensive overview of the sexual health concerns of gynecologic cancer survivors and discuss evidence-based treatment options for commonly encountered sexual health issues. Methods A comprehensive literature search of English language studies on sexual health in gynecologic cancer survivors and the treatment of sexual dysfunction was conducted in MEDLINE databases. Relevant data are presented in this review. Additionally, personal and institutional practices are incorporated where relevant. Results Sexual dysfunction is prevalent among gynecologic cancer survivors as a result of surgery, radiation, and chemotherapy--negatively impacting QoL. Many patients expect their healthcare providers to address sexual health concerns, but most have never discussed sex-related issues with their physician. Lubricants, moisturizers, and dilators are effective, simple, non-hormonal interventions that can alleviate the morbidity of vaginal atrophy, stenosis, and pain. Pelvic floor physical therapy can be an additional tool to address dyspareunia. Cognitive behavioral therapy has been shown to be beneficial to patients reporting problems with sexual interest, arousal, and orgasm. Conclusion Oncology providers can make a significant impact on the QoL of gynecologic cancer survivors by addressing sexual health concerns. Simple strategies can be implemented into clinical practice to discuss and treat many sexual issues. Referral to specialized sexual health providers may be needed to address more complex problems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889 · cited 1×
“The Women's Health Initiative reported systemic hormone replacement therapy with estrogen plus progestin is associated with an increased risk of coronary heart disease, stroke, and breast cancer and the risk of treatment outweighs the benefit [110].”
BackgroundSexual Dysfunction in the United States: Prevalence and Predictors
Laumann, E. O., Paik, A., & Rosen, R. C. (1999) · JAMA · doi:10.1001/jama.281.6.537 · Cited by 5,119 · cited 1×
“population is approximately 40% [4, 5], but can approach 90% in gynecologic oncology patients [6], with associated poor psychosocial adjustment and QoL [7].”
BackgroundA Study of sexuality and health among older adults in the United States
Lindau, S. T., Schumm, L. P., Laumann, E. O., Levinson, W., O'Muircheartaigh, C. A., & Waite, L. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067423 · Cited by 2,211 · cited 2×
“population is approximately 40% [4, 5], but can approach 90% in gynecologic oncology patients [6], with associated poor psychosocial adjustment and QoL [7].”
BackgroundSexual Problems and Distress in United States Women: Prevalence and Correlates
Shifren, J. L., Monz, B. U., Russo, P. A., Segreti, A., & Johannes, C. B. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181898cdb · Cited by 1,394 · cited 1×
“Low education, certain religious beliefs, and feeling guilty about sex are associated with female orgasmic disorder [92] and psychological risk factors include anxiety, depression, poor body-image, and a history of abuse [91, 93].”
BackgroundWalker, J. L., Piedmonte, M. R., Spirtos, N. M., Eisenkop, S. M., Schlaerth, J. B., Mannel, R. S., Spiegel, G., Barakat, R., Pearl, M. L., & Sharma, S. K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3248 · Cited by 1,288
Montejo-gonzàlez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De LA Gandara, J., et al. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403923 · Cited by 505 · cited 1×
“Selective serotonin reuptake inhibitors (SSRI) have well-established negative effects on sexual function with 31 – 57% of patients reporting delay or inhibition of orgasm [94].”
BackgroundWenzel, L. B., Donnelly, J. P., Fowler, J. M., Habbal, R., Taylor, T. H., Aziz, N., & Cella, D. (2002) · Psycho-Oncology · doi:10.1002/pon.567 · Cited by 277 · cited 2×
“Survivors experience decreased libido, decreased arousal, problems with orgasm, and difficulty with intercourse due to treatment related side effects [51-53].”
BackgroundRecommendations for the Clinical Evaluation of Men and Women with Sexual Dysfunction
Hatzichristou, D., Rosen, R. C., Derogatis, L. R., Low, W. Y., Meuleman, E. J. H., Sadovsky, R., & Symonds, T. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01619.x · Cited by 191 · cited 1×
“2) [74,75].”
Antidepressants and sexual dysfunction
Werneke, U., Northey, S., & Bhugra, D. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00890.x · Cited by 176
Metadata
- Authors
- Huffman, L. B., Hartenbach, E. M., Carter, J., Rash, J. K., & Kushner, D. M.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 140
- Issue
- 2
- Pages
- 359-368
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W2192388004
- Cited by
- 184
- References
- 9
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide. https://app.cochat.ai/papers/10.1016/j.ygyno.2015.11.010
- The paper
- Huffman, L. B., Hartenbach, E. M., Carter, J., Rash, J. K., & Kushner, D. M. (2016). Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2015.11.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.